Skip to main content
Have a personal or library account? Click to login
The spine and carina as a surrogate for target registration in cone-beam CT imaging verification in locally advanced lung cancer radiotherapy Cover

The spine and carina as a surrogate for target registration in cone-beam CT imaging verification in locally advanced lung cancer radiotherapy

Open Access
|Mar 2023

Figures & Tables

Figure 1

Automatic clip box carina registration with manual alignment check. Target contours (gross tumour volume [GTV] inner contour, planning target volume [PTV] outer contour) are imported for target registration.

Table 1

Patients, disease, and treatment characteristics

N = 40
GenderFemale16 (40 %)
Male24 (60 %)
Age (years)Median (range)67 (53–81)
RUL15 (37.5%)
RML3 (7.5%)
Tumour location*RLL7 (17.5%)
LUL8 (20%)
LLL8 (20%)
Central (C)/C17 (42.5%)
peripheral (P) tumour location**P22 (55%)
HistologyNSCLC31 (77.5%)
SCLC9 (22.5%)
De novo lung cancer32 (80%)
Local progression1 (2.5%)
Disease treatedLocal recurrence reirradiation2 (5%)
Regional recurrence1 (2.5%)
Locoregional recurrence reirradiation4 (10%)
Concurrent chemotherapy13 (32.5%)
Systemic treatmentSequential chemotherapy16 (40%)
Target therapy1 (2.5%)
None10 (25%)
T01 (2.5%)
T14 (10%)
Tumour (T) stageT214 (35%)
T38 (20%)
T413 (32.5%)
N09 (22.5%)
Lymph nodes (N)N11 (2.5%)
stageN214 (35%)
N316 (40%)
FractionationConventional37 (92.5%)
Hypofractionation3 (7.5%)
Radiation techniqueVMAT40 (100%)

[i] * In one patient, two synchronous tumours were treated (RUL and LUL).

**In one patient, only the lymph nodes were treated (regional recurrence).

LLL = left lower lobe; LUL = left upper lobe; NSCLC = non-small cell cancer; RML = right middle lobe; RLL = right lower lobe; RUL = right upper lobe; SCLC = small cell lung cancer; VMAT = volumetric modulated arc therapy

Figure 2

Spine to target (A) and carina to target (B) registration set-up deviation in the lateral (LAT), longitudinal (LONG) and vertical (VRT) directions.

Table 2

Mean set-up deviation difference (DD) comparison according to spine/target vs. carina/target registration

FractionSpine/targetCarina/targetDDp valueSpine/targetCarina/targetDDp valueSpine/targetCarina/targetDDp value
1st1.280.900.38NS2.651.800.85NS1.201.43-0.23NS
10th1.301.080.22NS2.031.530.50NS1.681.100.580.04
15th1.481.080.4NS2.381.650.730.051.381.380NS
20th1.531.050.48NS2.732.150.58NS1.21.43-0.23NS
All measurements1.391.030.370.0032.441.780.660.0021.361.330.03NS

[i] DD = deviation difference; LAT = lateral; LONG = longitudinal; NS = non-significant (p>0.05); target = primary tumour and lymph nodes; VRT = vertical

Table 3

Spine/target registration deviation according to tumour location

CentralPeripheralCentralPeripheralCentralPeripheral
1st0.711.770.0481.183.910.0021.121.32NS
10th0.761.770.0081.532.41NS1.411.860.017
15th1.471.55NS2.592.32NS1.351.45NS
20th1.941.27NS2.293.14NS1.291.09NS

[i] LAT = lateral; LONG = longitudinal; NS = non significant (p>0.05); target = primary tumour and lymph nodes; VRT = vertical

Table 4

Carina/target registration deviation according to tumour location

FractionLAT mean (mm)p valueLONG mean (mm)p valueVERT mean (mm)p value
CentralPeripheralCentralPeripheralCentralPeripheral
1st0.651.14NS1.652.00NS1.061.77NS
10th0.531.550.0021.181.860.0410.821.32NS
15th0.711.410.0491.002.230.0270.881.77NS
20th1.001.14NS0.943.140.0190.881.82NS

[i] LAT = lateral, LONG = longitudinal, NS = non significant (p>0.05); VRT = vertical; target = primary tumour and lymph nodes

DOI: https://doi.org/10.2478/raon-2022-0048 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 86 - 94
Submitted on: May 8, 2022
Accepted on: Oct 19, 2022
Published on: Mar 22, 2023
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Jasna But-Hadzic, Karmen Strljic, Valerija Zager Marcius, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.